Status:
COMPLETED
Mediastinal Staging of Lung Cancer With EBUS-TBNA and EUS-B-FNA
Lead Sponsor:
National Cancer Center, Korea
Conditions:
Lung Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to find a role of EUS-B-FNA in the mediastinal staging of potentially operable lung cancer. The investigators perform EBUS-TBNA and EUS-B-FNA on potentially operable lung ...
Eligibility Criteria
Inclusion
- Histologically confirmed or strongly suspected potentially operable non-small cell lung cancer (NSCLC)
- Potentially operable patients
Exclusion
- After staging work-up for NSCLC, including bronchoscopy,CT of the chest and upper abdomen, integrated PET/CT and brain MRI (and/or bone scan)
- M1 disease
- Inoperable T4 disease
- Mediastinal infiltration or extranodal invasion of the mediastinal lymph node visible on chest CT.
- Confirmed supraclavicular lymph node metastasis
- Pancoast tumors
- Medically inoperable patients
- Contraindications for bronchoscopy
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00741247
Start Date
August 1 2008
End Date
March 1 2009
Last Update
June 24 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NCCKorea
Gyeonggi-do, South Korea